<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120180</url>
  </required_header>
  <id_info>
    <org_study_id>JTU-6H-20211011001</org_study_id>
    <nct_id>NCT05120180</nct_id>
  </id_info>
  <brief_title>Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer</brief_title>
  <acronym>PLEDGE</acronym>
  <official_title>Postoperative Upper Limb Edema and Dysfunction Generated by Axillary Nodes Excision With or Without Axillary Vein Branches Reservation in Breast Cancer Patients: a Prospective, Multiple-center, Double-blinded, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangyun Zong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects of axillary lymph node dissection with or&#xD;
      without axillary vein branches reservation on the affected upper limb edema and dysfunction&#xD;
      in breast cancer patients, and to explore the solutions to prevent the affected upper limb&#xD;
      edema and dysfunction after ALND.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">March 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of lymphedema</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of upper limb lymphedema on affected side after operation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of dysfunction</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of upper limb dysfunction on affected side after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of lymphedema</measure>
    <time_frame>1 month, 6 month</time_frame>
    <description>Incidence of upper limb lymphedema on affected side after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of dysfunction</measure>
    <time_frame>1 month, 6 month</time_frame>
    <description>Incidence of upper limb dysfunction on affected side after operation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of lymphedema and dysfunction</measure>
    <time_frame>5 year</time_frame>
    <description>Incidence of upper limb lymphedema and dysfunction on affected side after operation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Breast Cancer Lymphedema</condition>
  <arm_group>
    <arm_group_label>Branches Sparing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in this arm will undergo axillary lymph node dissection with preserved axillary vein branches</description>
  </arm_group>
  <arm_group>
    <arm_group_label>None Branches Sparing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this arm will undergo axillary lymph node dissection without preserved axillary vein branches</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>axillary lymph node dissection with vein branches reservation</intervention_name>
    <description>Spare the vein branches when ALND being performed</description>
    <arm_group_label>Branches Sparing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>axillary lymph node dissection without vein branches reservation</intervention_name>
    <description>Don't spare the vein branches when ALND being performed</description>
    <arm_group_label>None Branches Sparing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-69 years old,&#xD;
&#xD;
          -  Regardless of gender,&#xD;
&#xD;
          -  Breast masses were diagnosed by histology and pathology, stage II -III.&#xD;
&#xD;
          -  Clinical palpation of axillary lymph nodes is positive, or&#xD;
&#xD;
          -  Axillary lymph node puncture pathology is positive, or&#xD;
&#xD;
          -  The multidisciplinary treatment cooperation group (MDT) recommends axillary lymph node&#xD;
             dissection,&#xD;
&#xD;
          -  Good physical state score (0-2),&#xD;
&#xD;
          -  No severe organ complications,&#xD;
&#xD;
          -  No congenital or acquired diseases affecting the normal morphology and functional&#xD;
             activities of the upper limbs,&#xD;
&#xD;
          -  Informed consent, understanding and compliance with research requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or lactation,&#xD;
&#xD;
          -  Inflammatory breast cancer,&#xD;
&#xD;
          -  Clinical findings of metastatic lesions,&#xD;
&#xD;
          -  Sentinel lymph node biopsy was negative,&#xD;
&#xD;
          -  History of upper limb or shoulder, chest, back trauma or surgery,&#xD;
&#xD;
          -  Previous history of local radiotherapy,&#xD;
&#xD;
          -  History of other tumors,&#xD;
&#xD;
          -  Vascular embolic disease,&#xD;
&#xD;
          -  Those who are unable to comply with the clinical trial requirements for any reason.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XIANGYUN ZONG, M.D., Ph.D.P</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Jiao Tong University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>FEN TANG, M.D., Ph.D.P</last_name>
    <phone>+86(21)24058549</phone>
    <email>690476877@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FEN TANG, MD</last_name>
      <phone>+86(21)24058549</phone>
      <email>690476877@qq.com</email>
    </contact>
    <investigator>
      <last_name>XIANGYUN ZONG, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhejiang Cancer Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YANG YU, M.D.</last_name>
      <phone>+86（21）88122222</phone>
      <email>yuyangkaiyu@163.com</email>
    </contact>
    <investigator>
      <last_name>HONGJIAN YANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>YANG YU, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</investigator_affiliation>
    <investigator_full_name>Xiangyun Zong</investigator_full_name>
    <investigator_title>Head of Breast Cancer, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Axillary Lymph Node Dissection</keyword>
  <keyword>Post-mastectomy Lymphedema</keyword>
  <keyword>Upper Limb Dysfunction</keyword>
  <keyword>Axillary Vein Branches Reservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
    <mesh_term>Breast Cancer Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

